- Research works
- 2 ▼ 62% vs 2013–17
- Citations
- 19 8.6 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 78% world 28%
Not ranked overall: Bioptech (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Bioptech (Sweden) publish most on?
By volume in 2022–2025: Wheat and Barley Genetics and Pathology, Plant Disease Resistance and Genetics, Plant Genetic and Mutation Studies and Single-cell and spatial transcriptomics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Wheat and Barley Genetics and Pathology Plant Science 0 works
- 2 Plant Disease Resistance and Genetics Plant Science 0 works
- 3 Plant Genetic and Mutation Studies Plant Science 0 works
- 4 Single-cell and spatial transcriptomics Molecular Biology 0 works
- 5 CRISPR and Genetic Engineering Molecular Biology 0 works
- 6 Renal and related cancers Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bioptech (Sweden)'s research output changed?
Output in 2018–2022 was 62% lower than in 2013–2017.
Other research institutions in Solna
- Bristol-Myers Squibb (Sweden)
- Abbott (Sweden)
- Public Health Agency of Sweden
- Stockholm International Peace Research Institute
- Swedish Space Corporation
- Radium Hemmets Research Funds
- Johnson & Johnson (Sweden)
- Karolinska Development (Sweden)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.